This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Immunohistochemical discrimination of wild-type EGFR from EGFRvIII in fixed tumour specimens using anti-EGFR mAbs ICR9 and ICR10
British Journal of Cancer Open Access 07 February 2012
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mitchell, P. Erbitux diagnostic latest adjunct to cancer therapy. Nat Biotechnol 22, 363–364 (2004). https://doi.org/10.1038/nbt0404-363
Issue Date:
DOI: https://doi.org/10.1038/nbt0404-363
This article is cited by
-
Immunohistochemical discrimination of wild-type EGFR from EGFRvIII in fixed tumour specimens using anti-EGFR mAbs ICR9 and ICR10
British Journal of Cancer (2012)
-
Emerging patent issues in genomic diagnostics
Nature Biotechnology (2006)
-
Cautious welcome for FDA pharmacogenomics guidance
Nature Biotechnology (2005)